Symptoms, Variability, and Emergency Red Flags
At a Glance
X-linked immunoneurologic disorder symptoms vary by gene and age, but sudden seizures, confusion, new weakness, severe headache, uncontrolled bleeding, yellow skin or eyes, a swollen abdomen, or severe lethargy require immediate emergency care; use the emergency plan for fever, vomiting, or diarrhea.
Symptoms of X-linked immunoneurologic disorders can be deceptive. They often begin with common issues—like a stubborn diaper rash, a few extra ear infections, or a teacher noticing a lack of focus—that gradually reveal a more complex underlying condition [1][2]. Because these disorders affect both the immune system and the brain, your care team will monitor for a wide range of changes.
Routine Monitoring and Daily Symptoms
Many symptoms of these conditions are managed through regular specialist visits. These are not typically emergencies, but they are important “clues” for your doctors:
- Recurrent Infections: These may include frequent ear infections, sinus infections, or pneumonia. In XMEN syndrome, you might see persistent viral skin lesions or upper respiratory issues [3][4].
- Skin and Blood Issues: In Wiskott-Aldrich Syndrome (WAS), infants often have eczema (itchy, inflamed skin) and small bruises or tiny red spots called petechiae caused by low platelet counts [5][6].
- Subtle Neurologic Changes: In cALD, early signs can be very quiet, such as a child becoming hyperactive, struggling to pay attention in school, or withdrawing socially. While these are often misdiagnosed as ADHD, any new loss of previously acquired skills warrants prompt assessment [7][8].
- Fatigue and Weakness: General tiredness or a lack of stamina can be a sign of chronic immune activation or early adrenal issues [2].
When to Seek a Same-Day Evaluation
Some symptoms aren’t emergency room “red flags” yet, but they cannot wait for your next routine appointment. Contact your specialist the same day if you notice:
- Increased bruising or small, new bleeding spots under the skin.
- A noticeable change in balance, “clumsiness,” or speech that seems slightly slurred [9][7].
Emergency Red Flags: When to Call 911 or Go to the ER
The following symptoms represent critical, life-threatening complications that require immediate medical intervention. Always follow your individualized emergency action plan provided by your specialist.
1. Hemophagocytic Lymphohistiocytosis (HLH)
This is a severe, rapidly evolving immune reaction most common in XLP1 and XLP2, often triggered by a virus like Epstein-Barr (EBV) [10]. Do not wait for a fever to “not go away.” Follow your specialist’s fever action plan immediately. Go to the ER for:
- Fever that meets your doctor’s specific threshold for action [11].
- Jaundice: Yellowing of the skin or the whites of the eyes [12].
- Abdominal Swelling: A very firm or distended belly, which can mean the liver or spleen is dangerously enlarged [11].
- Severe Lethargy: Being impossible to wake up or acting extremely confused.
2. Adrenal Crisis (cALD)
For patients with an ABCD1 mutation (cALD), vomiting or severe diarrhea with weakness can represent an adrenal crisis [13]. Follow your prescribed stress-dose steroid plan and seek immediate emergency care.
3. Acute Neurologic Crisis (Brain and Nerves)
Sudden changes in the brain can be caused by inflammation (vasculitis) or new progressive nerve damage [14][15]. Go to the ER for:
- Sudden Seizures: Especially if the person has never had a seizure before.
- Altered Mental Status: Sudden confusion, aggressive behavior changes, or a loss of consciousness [16][7].
- Severe, “Worst Ever” Headache: This can be a sign of high pressure in the brain or a bleed [17].
- New Focal Weakness: Sudden inability to move a limb or severe imbalance.
4. Severe Bleeding
In conditions like WAS, low platelets can lead to dangerous internal bleeding [1]. Go to the ER for:
- Blood in the stool (may look black and tarry or bright red).
- Heavy bleeding from the nose or gums that will not stop with pressure.
- Signs of a brain bleed (intracranial hemorrhage), such as a sudden, severe headache combined with vomiting or sleepiness [18].
The Role of Age and Timing
The way these symptoms appear can vary wildly based on the specific gene and the person’s age. WAS and XLP2 often show up in infancy or early childhood [1][19]. cALD symptoms frequently present in childhood but can occur at other ages [20]. In contrast, XMEN can be highly variable; some people are diagnosed as infants due to infections, while others may not show behavioral changes until adulthood [21][22]. Regardless of the age of onset, any sudden “drop off” in a person’s abilities or a rapid change in their health should be treated as an urgent priority [23].
Common questions in this guide
What symptoms mean that someone with an X-linked immunoneurologic disorder needs the ER?
What are the warning signs of HLH in XLP1 or XLP2?
When could vomiting signal an adrenal crisis in cALD?
Which neurologic changes should prompt urgent medical attention?
How can I tell if bleeding is an emergency in Wiskott-Aldrich syndrome?
Can symptoms of these disorders look different at different ages?
Get notified when new evidence is published on X-linked immunoneurologic disorder.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (23)
- 1
When WAS Gene Diagnosis Is Needed: Seeking Clues Through Comparison Between Patients With Wiskott-Aldrich Syndrome and Idiopathic Thrombocytopenic Purpura.
Jin YY, Wu J, Chen TX, Chen J
Frontiers in immunology 2019; (10()):1549 doi:10.3389/fimmu.2019.01549.
PMID: 31354712 - 2
Primary Adrenal Insufficiency in a Boy with Type I Diabetes: The Importance of Considering X-linked Adrenoleukodystrophy.
Wiersma RE, Gupta AO, Lund TC, et al.
Journal of the Endocrine Society 2022; (6(5)):bvac039 doi:10.1210/jendso/bvac039.
PMID: 35450414 - 3
[X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia: report of a family and literature review].
He TY, Xia Y, Li CG, et al.
Zhonghua er ke za zhi = Chinese journal of pediatrics 2018; (56(1)):48-52 doi:10.3760/cma.j.issn.0578-1310.2018.01.013.
PMID: 29342998 - 4
[Two families of X-linked lymphoproliferative disease type 1 characterized by agammaglobulinemia].
Li WY, Chen JS, Zhao Q, et al.
Zhonghua er ke za zhi = Chinese journal of pediatrics 2017; (55(5)):377-382 doi:10.3760/cma.j.issn.0578-1310.2017.05.014.
PMID: 28482391 - 5
Screening for Wiskott-Aldrich Syndrome in Chronic Idiopathic Thrombocytopenic Purpura.
Deivasigamani P, Basu S, Rikhi R, et al.
Indian journal of pediatrics 2025; (92(10)):1104-1106 doi:10.1007/s12098-025-05712-6.
PMID: 40794232 - 6
Wiskott Aldrich Syndrome: A Multi-Institutional Experience From India.
Suri D, Rikhi R, Jindal AK, et al.
Frontiers in immunology 2021; (12()):627651 doi:10.3389/fimmu.2021.627651.
PMID: 33936041 - 7
[X-linked adrenoleukodystrophy: A case of acute childhood cerebral presentation].
Posada Bustos S, Charry Lopez ML, Espinosa García E
Andes pediatrica : revista Chilena de pediatria 2021; (92(4)):602-608 doi:10.32641/andespediatr.v92i4.3345.
PMID: 34652380 - 8
Psychiatric disease in an adolescent as a harbinger of cerebral X-linked adrenoleukodystrophy.
Smith J, Williams MT, Misra VK
Practical neurology 2018; (18(3)):242-245 doi:10.1136/practneurol-2017-001718.
PMID: 29175874 - 9
Case Report: Incidental diagnosis of cystic fibrosis via whole genome sequencing alters HSCT planning in a child with cerebral X-linked adrenoleukodystrophy.
Sy JAC, Tan PL, Lin JB, et al.
Frontiers in pediatrics 2025; (13()):1650645 doi:10.3389/fped.2025.1650645.
PMID: 40861057 - 10
X-linked lymphoproliferative disease type 1: a clinical and genetic update.
Li J, Lv L, Wei Q, et al.
Frontiers in immunology 2025; (16()):1620327 doi:10.3389/fimmu.2025.1620327.
PMID: 40574867 - 11
Pediatric hemophagocytic lymphohistiocytosis.
Canna SW, Marsh RA
Blood 2020; (135(16)):1332-1343 doi:10.1182/blood.2019000936.
PMID: 32107531 - 12
[X-linked lymphoproliferative syndrome type 1 complicated with secondary hemophagocytic lymphohistiocytosis and ileal perforation: case report and literature review].
Xiao L, Guan XM, Meng Y, et al.
Zhonghua er ke za zhi = Chinese journal of pediatrics 2016; (54(4)):290-3 doi:10.3760/cma.j.issn.0578-1310.2016.04.013.
PMID: 27055430 - 13
Recurrent episodes of vomiting and diarrhoea in a male child: a rare presentation of X-linked adrenoleukodystrophy.
Gupta P, Keller SR, Patterson B
BMJ case reports 2022; (15(8)) doi:10.1136/bcr-2022-249905.
PMID: 35948360 - 14
The neurologic face of X-linked lymphoproliferative syndrome type 1: a systematic review.
Rajabi E, Gharagozlou S, Farhadi K, et al.
Orphanet journal of rare diseases 2025; (20(1)):528 doi:10.1186/s13023-025-04057-9.
PMID: 41121205 - 15
Adrenoleukodystrophy in the Differential Diagnosis of Boys Presenting with Primary Adrenal Insufficiency without Adrenal Antibodies
Ryalls MR, Gan HW, Davison JE
Journal of clinical research in pediatric endocrinology 2021; (13(2)):212-217 doi:10.4274/jcrpe.galenos.2020.2020.0214.
PMID: 32394691 - 16
Childhood cerebral X-linked adrenoleukodystrophy with atypical neuroimaging abnormalities and a novel mutation.
Muranjan M, Karande S, Sankhe S, Eichler S
Journal of postgraduate medicine 2018; (64(1)):59-63 doi:10.4103/jpgm.JPGM_349_17.
PMID: 29386416 - 17
Case report: Non-EBV associated cerebral vasculitis and cerebral hemorrhage in X-linked lymphoproliferative disease.
Li B, Chen W, Cai X, et al.
Frontiers in immunology 2024; (15()):1381472 doi:10.3389/fimmu.2024.1381472.
PMID: 38726008 - 18
The spectrum of bleeding in Wiskott-Aldrich syndrome: a systematic review and meta-analysis of incidence and mortality.
Yang Z, Tang Z, Zhou L, et al.
Frontiers in immunology 2026; (17()):1854833 doi:10.3389/fimmu.2026.1854833.
PMID: 42519333 - 19
X-linked inhibitor of apoptosis protein deficiency: more than an X-linked lymphoproliferative syndrome.
Aguilar C, Latour S
Journal of clinical immunology 2015; (35(4)):331-8 doi:10.1007/s10875-015-0141-9.
PMID: 25737324 - 20
Adult onset cerebral adrenoleukodystrophy: report of an atypical case.
Coucke A, Vanacker P, Dutoit J, et al.
Acta neurologica Belgica 2026; (126(2)):687-689 doi:10.1007/s13760-025-02968-9.
PMID: 41372736 - 21
Adult-onset neurodegeneration in XMEN disease.
Benavides D, Ebrahim A, Ravell JC, et al.
Journal of neuroimmunology 2024; (386()):578251 doi:10.1016/j.jneuroim.2023.578251.
PMID: 38041964 - 22
Case Report: A successful case of allogeneic stem cell transplantation for pediatric XMEN characterized by neutropenia.
Tian J, Zheng J, Qin M, et al.
Frontiers in immunology 2026; (17()):1687549 doi:10.3389/fimmu.2026.1687549.
PMID: 41624006 - 23
Comprehensive clinical and immunologic characterization of Wiskott-Aldrich syndrome in Iran: a 10-year cohort study.
Esmaeilzadeh H, Gholami MA, Dehghani SS, et al.
BMC immunology 2025; (26(1)):97 doi:10.1186/s12865-025-00779-4.
PMID: 41345550
This page is for informational purposes only and does not constitute medical advice or replace your specialist’s individualized emergency plan. Contact your specialist or emergency services for urgent symptoms.